Trade Mark Journal No.2024/020 17 May 2024
WO0000001777616 (5)
Office of origin: United States of America
Date of International Registration:4 January 2024
Date of designation in the UK:
4 January 2024

International priority date claimed: 12 July 2023
(United States of America)
(98082360)
- Class 5
- Medical hydrogel for protecting nerve ends and preventing the development of symptomatic neuroma.
Tulavi Therapeutics, Inc.
Representative: Knobbe, Martens, Olson & Bear LLP, 2040 Main Street, 14th Floor, Irvine CA 92614, UNITED STATES OF AMERICA